Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-027002
Filing Date
2025-08-14
Accepted
2025-08-14 17:02:57
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20250630_10q.htm   iXBRL 10-Q 1228852
2 EXHIBIT 31.1 ex_847052.htm EX-31.1 8314
3 EXHIBIT 31.2 ex_847053.htm EX-31.2 8355
4 EXHIBIT 32.1 ex_847054.htm EX-32.1 6516
  Complete submission text file 0001437749-25-027002.txt   5188374

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA tlph-20250630.xsd EX-101.SCH 50113
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlph-20250630_def.xml EX-101.DEF 310816
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlph-20250630_lab.xml EX-101.LAB 280476
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlph-20250630_pre.xml EX-101.PRE 338452
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlph-20250630_cal.xml EX-101.CAL 24167
63 EXTRACTED XBRL INSTANCE DOCUMENT acrx20250630_10q_htm.xml XML 774849
Mailing Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404
Business Address 1850 GATEWAY DRIVE SUITE 175 SAN MATEO CA 94404 650-216-3500
TALPHERA, INC. (Filer) CIK: 0001427925 (see all company filings)

EIN.: 412193603 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 251220750
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)